Calamos Advisors’s DTRT Health Acquisition Corp. Warrant DTRTW Stock Holding History

Calamos Advisors’s Portfolio DTRTW Stock Details DTRTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-150,000	Closed	-$45K	–	1309
2022 Q4	$45K	Hold	150,000	–	–	﹤0.01%	991
2022 Q3	$30K	Buy	+150,000	New	+$9.72K	﹤0.01%	1103

Calamos Advisors's DTRTW Position: Q1 2023 in Review

Calamos Advisors sold out of DTRT Health Acquisition Corp. Warrant (DTRTW) in Q1 2023, closing a stake of 150,000 shares — an estimated $45K sold.

Calamos Advisors first reported a position in DTRTW in Q3 2022 and held it in 2 quarters. The position peaked at $45K in Q4 2022. 0 funds tracked by Wall St. Rank hold DTRTW as of Q1 2023.

Calamos Advisors reported no remaining DTRT Health Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Calamos Advisors sold 150,000 DTRT Health Acquisition Corp. Warrant shares in Q1 2023, an estimated $45K.
Calamos Advisors first reported a position in DTRT Health Acquisition Corp. Warrant in Q3 2022 and held it in 2 quarters.
Calamos Advisors's DTRT Health Acquisition Corp. Warrant position peaked at $45K in Q4 2022.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Warrant as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.